Evidence map›Paper›PMID 38694035›Full record

ArticleHeliyon2024

CerviLearnNet: Advancing cervical cancer diagnosis with reinforcement learning-enhanced convolutional networks.

Shakhnoza Muksimova, Sabina Umirzakova, Seokwhan Kang, Young Im Cho

Abstract read
In one paragraph

Article in Heliyon, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 14 papers.

0numbers the graph read from it
0cells of the map it votes in
14citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

14 citing papers in PubMed.

  1. Article
  2. Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors.

Shakhnoza MuksimovaDepartment of Computer Engineering, Gachon University, Sujeong-gu, Seongnam-si 461-701, Gyeonggi-do, South Korea.
Sabina UmirzakovaDepartment of Computer Engineering, Gachon University, Sujeong-gu, Seongnam-si 461-701, Gyeonggi-do, South Korea.
Seokwhan KangDepartment of Computer Engineering, Gachon University, Sujeong-gu, Seongnam-si 461-701, Gyeonggi-do, South Korea.
Young Im ChoDepartment of Computer Engineering, Gachon University, Sujeong-gu, Seongnam-si 461-701, Gyeonggi-do, South Korea.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Women tend to face many problems throughout their lives; cervical cancer is one of the most dangerous diseases that they can face, and it has many negative consequences. Regular screening and treatment of precancerous lesions play a vital role in the fight against cervical cancer. It is becoming increasingly common in medical practice to predict the early stages of serious illnesses, such as heart attacks, kidney failure, and cancer, using machine learning-based techniques. To overcome these obstacles, we propose the use of auxiliary modules and a special residual block, to record contextual interactions between object classes and to support the object reference strategy. Unlike the latest state-of-the-art classification method, we create a new architecture called the Reinforcement Learning Cancer Network, "RL-CancerNet", which diagnoses cervical cancer with incredible accuracy. We trained and tested our method on two well-known publicly available datasets, SipaKMeD and Herlev, to assess it and enable comparisons with earlier methods. Cervical cancer images were labeled in this dataset; therefore, they had to be marked manually. Our study shows that, compared to previous approaches for the assignment of classifying cervical cancer as an early cellular change, the proposed approach generates a more reliable and stable image derived from images of datasets of vastly different sizes, indicating that it will be effective for other datasets.

Indexed as

Artificial intelligenceCervical cancerClassificationDeep learningMachine learningReinforcement learning

Identifiers

PMID38694035
PMCPMC11061669

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.